-
Something wrong with this record ?
The Contributory Role of Cell Blocks in Salivary Gland Neoplasms Fine Needle Aspirations Classified by the Milan System for Reporting Salivary Gland Cytology
E. Tommola, D. Kalfert, H. Hakso-Mäkinen, I. Kholová
Language English Country Switzerland
Document type Journal Article
Grant support
X5211
Pirkanmaan Sairaanhoitopiiri
Support Foundation
Pirkanmaan Sairaanhoitopiiri
2019
Tampereen Tuberkuloosisäätiö
Progres Q28/LF1 (UNCE 204013)
Univerzita Karlova v Praze
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- Publication type
- Journal Article MeSH
(1) Background: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was introduced in 2018, bringing an organ-specific classification system for salivary gland cytopathology. The aim of present study is to evaluate the MSRSGC prospectively, based on a two-year experience in the tertiary care center pathology department, and evaluate the role of routine cell block (CB) preparation in salivary gland cytopathological diagnostics. (2) Methods: In our institution, the Department of Pathology, Fimlab Laboratories, Tampere, Finland, the MSRSGC has been implemented in salivary gland cytopathology since January 2018 and, over a two-year period (January 2018-December 2019), there were 365 fine-needle aspirations, of which 164 had a surgical follow-up. The CB methods used were Plasma-thrombin, the collection of visible fragments, and the Shandon and in-house methods. (3) Results: The MSRSGC diagnostic figures were as follows: accuracy 87.5%, sensitivity 45.8% and specificity 98.9%. For diagnostic categories of MSRSGC (non-neoplastic, benign neoplasm and malignant neoplasm) (n = 63) diagnostic accuracy was 98.4%, and for undetermined categories (atypia of undetermined significance, salivary gland neoplasm of uncertain malignant potential and suspicious for malignancy) (n = 49) diagnostic accuracy was 73.5%. Non-contributory cell blocks resulted more often in a false negative diagnosis (25%, 3/12) than a true negative diagnosis (10%, 7/73, p < 0.001), and is, most likely, an insufficient cytological diagnosis (86%, 18/21, p < 0.001). (4) Conclusion: The application of MSRSGC and CBs are beneficial in salivary gland cytological diagnosis, increasing diagnostic accuracy and, thus, patients' management and treatment.
Faculty of Medicine and Health Technology Tampere University 33520 Tampere Finland
Fimlab Laboratories Department of Pathology Tampere University Hospital 33520 Tampere Finland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001679
- 003
- CZ-PrNML
- 005
- 20220112153656.0
- 007
- ta
- 008
- 220107s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/diagnostics11101778 $2 doi
- 035 __
- $a (PubMed)34679476
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Tommola, Erkka $u Fimlab Laboratories, Department of Pathology, Tampere University Hospital, 33520 Tampere, Finland $u Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
- 245 14
- $a The Contributory Role of Cell Blocks in Salivary Gland Neoplasms Fine Needle Aspirations Classified by the Milan System for Reporting Salivary Gland Cytology / $c E. Tommola, D. Kalfert, H. Hakso-Mäkinen, I. Kholová
- 520 9_
- $a (1) Background: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was introduced in 2018, bringing an organ-specific classification system for salivary gland cytopathology. The aim of present study is to evaluate the MSRSGC prospectively, based on a two-year experience in the tertiary care center pathology department, and evaluate the role of routine cell block (CB) preparation in salivary gland cytopathological diagnostics. (2) Methods: In our institution, the Department of Pathology, Fimlab Laboratories, Tampere, Finland, the MSRSGC has been implemented in salivary gland cytopathology since January 2018 and, over a two-year period (January 2018-December 2019), there were 365 fine-needle aspirations, of which 164 had a surgical follow-up. The CB methods used were Plasma-thrombin, the collection of visible fragments, and the Shandon and in-house methods. (3) Results: The MSRSGC diagnostic figures were as follows: accuracy 87.5%, sensitivity 45.8% and specificity 98.9%. For diagnostic categories of MSRSGC (non-neoplastic, benign neoplasm and malignant neoplasm) (n = 63) diagnostic accuracy was 98.4%, and for undetermined categories (atypia of undetermined significance, salivary gland neoplasm of uncertain malignant potential and suspicious for malignancy) (n = 49) diagnostic accuracy was 73.5%. Non-contributory cell blocks resulted more often in a false negative diagnosis (25%, 3/12) than a true negative diagnosis (10%, 7/73, p < 0.001), and is, most likely, an insufficient cytological diagnosis (86%, 18/21, p < 0.001). (4) Conclusion: The application of MSRSGC and CBs are beneficial in salivary gland cytological diagnosis, increasing diagnostic accuracy and, thus, patients' management and treatment.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kalfert, David $u Department of Otorhinolaryngology and Head and Neck Surgery, First Faculty of Medicine, University Hospital Motol, Charles University, 15006 Prague, Czech Republic
- 700 1_
- $a Hakso-Mäkinen, Heli $u Fimlab Laboratories, Department of Pathology, Tampere University Hospital, 33520 Tampere, Finland
- 700 1_
- $a Kholová, Ivana $u Fimlab Laboratories, Department of Pathology, Tampere University Hospital, 33520 Tampere, Finland $u Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
- 773 0_
- $w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 11, č. 10 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34679476 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20220112153652 $b ABA008
- 999 __
- $a ind $b bmc $g 1745569 $s 1152826
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 11 $c 10 $e 20210927 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
- GRA __
- $a X5211 $p Pirkanmaan Sairaanhoitopiiri
- GRA __
- $a Support Foundation $p Pirkanmaan Sairaanhoitopiiri
- GRA __
- $a 2019 $p Tampereen Tuberkuloosisäätiö
- GRA __
- $a Progres Q28/LF1 (UNCE 204013) $p Univerzita Karlova v Praze
- LZP __
- $a Pubmed-20220107